Versant Vantage II GP-GP, LLC
10% owner at LENZ
- Sold, on record
- $26.6M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Sep 30, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- LENZLENZ Therapeutics, Inc.10% owner
Sales by reason
0
Routine
0
Plan not stated
3
No plan
0
Unusual
Form 4 sales per month, every sale on record.
Timeline
- Sep 30, 2025No plan
Sold 17.6% of their holdings
$10.4M224,974 shares at $46.01
- Jun 27, 2025No plan
Sold 10.2% of their holdings
$6.1M200,000 shares at $30.47
- Jun 10, 2025No plan
Sold 21.9% of their holdings
$10.2M350,000 shares at $29.00
3 of 3
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | Oct 2, 2025 | LENZ | 10% owner | Sold | 224,974 | $46.01 | $10.4M | 764,127 | SEC |
| Jun 27, 2025 | Jul 1, 2025 | LENZ | 10% owner | Sold | 200,000 | $30.47 | $6.1M | 1.8M | SEC |
| Jun 10, 2025 | Jun 12, 2025 | LENZ | 10% owner | Sold | 350,000 | $29.00 | $10.2M | 1.2M | SEC |
| Jun 29, 2021 | Jul 1, 2021 | LENZ | 10% owner | Bought | 180,000 | $17.00 | $3.1M | 1.7M | SEC |
| Jun 29, 2021 | Jul 1, 2021 | LENZ | 10% owner | ConvertedSeries A Preferred Stock | 33.7M | 0 | SEC | ||
| Jun 29, 2021 | Jul 1, 2021 | LENZ | 10% owner | Converted | 13.9M | 1.5M | SEC |